House Passes Bill To Give FDA Drug Recall Power, Boost Supply Chain

The bipartisan bloc No. 2, offered by Rep. Suzanne Bonamici (D-OR), passed the House 262-168. It included just one health-related amendment from Reps. Chrissy Houlahan (D-PA) and Peter Meijer (R-MI). That amendment would codify recommendations included in a September HHS Office of the Inspector General report on pharmaceutical supply chain weaknesses.